ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,870,915 | +62.2% | 541,920 | +128.1% | 0.01% | +50.0% |
| Q2 2023 | $6,703,260 | +1324654.9% | 237,620 | +708.4% | 0.00% | – |
| Q1 2023 | $506 | -21.9% | 29,394 | -8.7% | 0.00% | – |
| Q4 2022 | $648 | -100.0% | 32,186 | -68.0% | 0.00% | -100.0% |
| Q3 2022 | $2,181,000 | +57.6% | 100,672 | +235.6% | 0.00% | 0.0% |
| Q1 2022 | $1,384,000 | -67.7% | 30,000 | -41.1% | 0.00% | -66.7% |
| Q4 2021 | $4,284,000 | +205.3% | 50,966 | +93.3% | 0.00% | +200.0% |
| Q2 2021 | $1,403,000 | -74.8% | 26,368 | -79.4% | 0.00% | -75.0% |
| Q1 2021 | $5,564,000 | – | 128,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |